SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HGR - Undervalued at 15 ( acquired novacare/will 2x reven

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ed Ajootian who wrote (9)1/5/2000 12:54:00 AM
From: judge  Read Replies (1) of 14
 
Ed,
My brother still optomistic about the company.. they continue to grow earnings and revenue.. You are absolutely correct on the savings they should reap, b/c of the economies of scale..

Another positive... Hgr "the company" has performed extremely well.. They have beaten estimates the past 4 qtrs.. Earnings for 2000 are estimated to grow 28% to 1.13 a share........Its the "stock" that has performed poorly.. The clinton health plan has scared many investors away...in my opinion.. With a market cap of only 180 million and sales next year to reach almost 400 million.. hgr is definitely a good value.. When the stock will follow the value is the only question.. 3-5 years down the road I think you will be happy you bought hgr.. In the short term, its hard to tell what will drive this stock higher.. j
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext